For the Inventor, By the Inventor

Enter assignee name

Burlington, MA, United States of America

Marine Polymer Technologies, Inc.

USPTO Granted Patents = 39

CIPO Patents = 4

EPO Patents = 12

Trademarks = 15

Forward Citations = 762

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Sergio Finkielsztein (38 out of 44 patents)

John N Vournakis (38 out of 45 patents)

Ernest R Pariser (13 out of 15 patents)

4. Mike Helton (12 out of 14 patents)

5. Marco Finkielsztein (3 out of 3 patents)

6. Giorgio Pietramaggiori (2 out of 2 patents)

7. Dennis Paul Orgill (2 out of 13 patents)

8. Sergio Finkielstein (1 out of 1 patent)

9. Marina V Demcheva (0 patent)

10. Ernst R Pariser (0 patent)

11. Sergio Finkeilsztein (0 patent)

12. Giorgio Pietramaggiori (0 patent)

13. Dennis P Orgill (0 patent)

14. Dennis P Orgill (0 patent)

15. Giorgio Pietramaggiori (0 patent)

39 patents: Sort by Forward Citations

1. 10765698 - Treatment of disease with poly-N-acetylglucosamine nanofibers (2020-09-08),

2. 10561677 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2020-02-18),

3. 10383971 - Hemostatic compositions and therapeutic regimens (2019-08-20),

4. 10252040 - Application of polymeric materials to screens to facilitate hemostasis and wound healing (2019-04-09),

5. 10206938 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2019-02-19),

6. 10206683 - Methods and apparatus for a manual vascular compression device (2019-02-19),

7. 9867625 - Methods and apparatus for a manual radial artery compression device (2018-01-16),

8. 9642871 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2017-05-09),

9. 9320653 - Hemostatic compositions and uses therefor (2016-04-26),

10. 9198928 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2015-12-01),

11. 9139664 - Hemostatic compositions and therapeutic regimens (2015-09-22),

12. 9139663 - Hemostatic compositions and therapeutic regimens (2015-09-22),

13. 8992453 - Vascular access preservation in hemodialysis patients (2015-03-31),

14. 8871247 - Hemostatic compositions and therapeutic regimens (2014-10-28),

15. 8859528 - Compositions and methods for modulation of vascular structure and/or function (2014-10-14),

Marine Polymer Technologies, Inc. is a leading biotechnology company specializing in advanced biomaterials and polymer technologies for medical and non-medical applications. With a focus on marine-derived materials, the company develops innovative products for wound care, biomaterial coatings, tissue regeneration, and hemostatic applications. By leveraging cutting-edge research and development, Marine Polymer Technologies aims to improve patient outcomes and enhance performance across various industries. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#17 in Burlington, MA

#497 in Massachusetts

#8,541 in US

#16,945 in the World

Burlington, MA, United States of America

Marine Polymer Technologies, Inc.

Forward Citations = 762

8 inventors:

Sergio Finkielsztein (38 out of 44 patents)

John N Vournakis (38 out of 45 patents)

Ernest R Pariser (13 out of 15 patents)

4. Mike Helton (12 out of 14 patents)

5. Marco Finkielsztein (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…